Is empiric proton pump inhibition in patients with symptoms of extraesophageal gastroesophageal reflux justified?

BACKGROUND: The prevalence of gastroesophageal reflux disease (GERD) has had a marked increase in Western countries with a paralleling interest in extraesophageal (EE) manifestations of GERD, including laryngopharyngeal reflux (LPR). There are considerable differences in clinical practice between ga...

Descripción completa

Detalles Bibliográficos
Autores principales: Fossmark, Reidar, Ness-Jensen, Eivind, Sørdal, Øystein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483799/
https://www.ncbi.nlm.nih.gov/pubmed/37674110
http://dx.doi.org/10.1186/s12876-023-02945-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483799/
https://www.ncbi.nlm.nih.gov/pubmed/37674110
http://dx.doi.org/10.1186/s12876-023-02945-7

Ejemplares similares